Allstate Corp Bei Gene, Ltd. Transaction History

Allstate Corp

  • $1.4 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$221.31 - $316.61 $225,957 - $323,258
-1,021 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$189.18 - $286.44 $193,152 - $292,455
1,021 New
1,021 $292,000
Q1 2020

May 15, 2020
SELL
$121.84 - $173.19 $506,367 - $719,777
-4,156 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$115.78 - $208.34 $481,181 - $865,861
4,156 New
4,156 $689,000

Others Institutions Holding BGNE

# of Institutions
216
Shares Held
45.1M
Call Options Held
76.5K
Put Options Held
72.3K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $15B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email